"In a pandemic, preventing any infection is desirable, because it slows the spread of the virus," says Jeffrey Haspel. "Based on our large data set, for children and older adults in particular, it can't hurt to try to have them vaccinated in the late morning and early afternoon." MirageC/Getty images
Time Of Day May Affect COVID Vaccine Effectiveness
Time of day may be important for how effective the COVID-19 vaccine is. A new study suggests middle of the day may be be best.
The COVID-19 vaccine may be more effective at preventing infections if doses are given around the middle of the day rather than at other times, according to a new study.
The researchers believe circadian rhythm—the natural cycle of physical and other changes our bodies go through in a 24-hour period—may affect the body’s response to the vaccine.
The correlation was strongest in children, teenagers, and adults over age 50.
“This type of information may be critical during a mass vaccination campaign, because if you can target priority groups—such as the young and the elderly, who our data suggest stand to benefit the most from midday COVID-19 vaccines—and vaccinate them during optimal times of day, that should create a significant societal benefit in reducing breakthrough infections,” says senior author Jeffrey A. Haspel, an associate professor of medicine in the division of pulmonary and critical care medicine at Washington University in St. Louis.
“Our data is specific to COVID-19 vaccination, but there are some small studies that also suggest vaccination for influenza may be more effective earlier in the day. Since these trends track with a basic biological phenomenon, it is possible this pattern is reflective of vaccinations in general. But we need more research to confirm that.”
The study, published in the Journal of Clinical Investigation, included data from more than 1.5 million people over age 12 who were enrolled in a large, Israeli health insurance plan. Nearly all had received the Pfizer mRNA vaccine. In Israel, the fourth dose (sometimes referred to as the second booster) was only offered to immunocompromised patients and older, healthy adults. For analysis purposes, morning was considered 8 am to noon; afternoon was noon to 4 pm; and evening was 4 to 7 pm.
Among older adults and people who were immunosuppressed, each of whom had received a fourth vaccine dose, more hospitalizations were seen among those who had received the fourth shot after 4 pm.
Depending on a person’s age, the vaccine’s effectiveness improved from 8.6% to 25% when given around the middle of the day, compared with when given in the evening.
To give an idea of the size of this effect on a population scale, the researchers estimate that moving 18 to 55 people from the least favorable vaccination time frame (4 to 7 pm) to the most favorable time frame (10 am to 2 pm) would prevent one post-vaccination infection.
“In a pandemic, preventing any infection is desirable, because it slows the spread of the virus,” Haspel says. “Over hundreds of millions of people, a benefit the size we estimated can have a huge impact. Based on our large data set, for children and older adults in particular, it can’t hurt to try to have them vaccinated in the late morning and early afternoon.”
The researchers found this general pattern remained consistent when they controlled for sex and pre-existing conditions. The benefit also was present for adults in the middle of the age range, but the size of the effect was smaller.
Basic research in mice and other organisms, including work in Haspel’s lab, has demonstrated that the biological clock regulates how some genes are expressed, dialing them up and down in a wave pattern depending on the time of day.
Various components of the immune system show these day-night rhythms, including innate inflammatory responses, the movement of immune cells from the bone marrow to various organs and lymph nodes, and how T cells respond to outside invaders.
“This observational study can’t demonstrate whether any of these specific immune system rhythms are responsible for the cycling we see in vaccine effectiveness,” Haspel says. “But we’re very interested in investigating these questions further.”
The National Institutes of Health and internal funds from the Department of Medicine at Washington University School of Medicine in St. Louis supported the work.